iCrowdNewswire
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Jun 21, 2019 9:57 AM ET

Celsus Therapeutics (formerly Morria Biopharmaceuticals) is a drug development company focusing on novel anti-inflammatory,


Celsus Therapeutics (formerly Morria Biopharmaceuticals) is a drug development company focusing on novel anti-inflammatory,

iCrowd Newswire - Jun 21, 2019

Celsus Therapeutics (formerly Morria Biopharmaceuticals) is a drug development company focusing on novel anti-inflammatory, first-in-class synthetic drugs termed Multi-Functional Anti-Inflammatory Drugs (MFAIDs). Celsuss proprietary drug technology platform is unique and potentially offers an answer to an urgent unmet need: the lack of satisfactory alternatives to corticosteroids in the treatment of a multitude of inflammatory diseases. The company has assembled an experienced team that shares its vision and is committed to making it a success.

Contact Information:

Dov Elefant








Tags:    Equity Crowdfunding, Wire, United Kingdom, English